Comments
Loading...

Silence Therapeutics Earnings Estimates

SLNNASDAQ
Logo brought to you by Benzinga Data

Silence Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SLN | Benzinga

Silence Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 27
EPS
$0.270
Quarterly Revenue
$24.86M
Annual Revenue
(as of Dec 31)
$43.26M

Analyze the earnings history of Silence Therapeutics using advanced sorting and filters.

Get Alert
SLNSilence Therapeutics-$0.05$15.73M05/15/2025Get Alert
SLNSilence Therapeutics-$0.16$0.27$2.61M$24.86M02/27/2025Get Alert
SLNSilence Therapeutics-$0.09-$0.75$3.54M$1.49M11/14/2024Get Alert
SLNSilence Therapeutics-$9.60-$0.42$9.10M$754.50K08/15/2024Get Alert
SLNSilence Therapeutics-$0.12-$0.05$13.81M$15.73M05/16/2024Get Alert
SLNSilence Therapeutics-$0.15-$0.16$5.59M$2.61M03/13/2024Get Alert
SLNSilence Therapeutics-$0.08-$0.09$3.97M$3.54M11/14/2023Get Alert
SLNSilence Therapeutics-$0.12$4.58M$11.38M08/16/2023Get Alert
SLNSilence Therapeutics-$0.12-$0.12$7.68M$13.81M05/16/2023Get Alert
SLNSilence Therapeutics-$0.14-$0.15$4.60M$5.59M03/15/2023Get Alert
SLNSilence Therapeutics-$0.08$3.97M11/10/2022Get Alert
SLNSilence Therapeutics08/11/2022Get Alert
SLNSilence Therapeutics-$0.12$7.68M05/16/2022Get Alert
SLNSilence Therapeutics-$0.14$4.60M03/17/2022Get Alert

Silence Therapeutics (SLN) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %

Silence Therapeutics (SLN) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Silence Therapeutics (NASDAQ:SLN) reporting earnings?

A

Silence Therapeutics (SLN) is scheduled to report earnings on May 15, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.

Q

What were the latest earnings per share (EPS) for Silence Therapeutics (NASDAQ:SLN)?

A

The Actual EPS was $0.27, which beat the estimate of $0.00.

Q

What were Silence Therapeutics’s (NASDAQ:SLN) revenues?

A

The Actual Revenue was $24.9M, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch